Search Within

Christopher Yongchul Park

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (9)
  2. Epidemiology and Biostatistics (9)
  3. Adult Leukemia (7)
  4. Center for Hematologic Malignancies (7)
  5. Department of Medicine (7)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Sean Devlin (9)
  2. Stephen Chung (7)
  3. Alec Stranahan (2)
  4. Carolien Woolthuis (2)
  5. Daniel Royston (2)
  6. Mikhail Roshal (2)

More People

Years
  1. 2016 (4)
  2. 2015 (1)
  3. 2014 (3)
  4. 2013 (1)
Publications
  1. Laboratory Investigation (3)
  2. Modern Pathology (3)
  3. Blood (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. New England Journal of Medicine (1)
Publishers
  1. Nature Publishing Group (3)
  2. Nature Research (3)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. Massachusetts Medical Society (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Leukemic stem cell responses to induction chemotherapy identify novel prognostic biomarkers in acute myeloid leukemia
    Meeting Abstract

    Raciti, P.; Hu, W. H.; Stranahan, A.; Woolthuis, C.; Devlin, S.; Park, C.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • CD164: A novel marker distinguishing hematopoietic stem/progenitor cells (HSPC) from leukemic stem cells
    Meeting Abstract

    Royston, D.; Gao, Q.; Tavakkoli, M.; Chung, S. S.; Devlin, S.; Roshal, M.; Park, C.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • CD164: A novel marker distinguishing hematopoietic stem/progenitor cells (HSPC) from leukemic stem cells
    Meeting Abstract

    Royston, D.; Gao, Q.; Tavakkoli, M.; Chung, S. S.; Devlin, S.; Roshal, M.; Park, C.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Leukemic stem cell responses to induction chemotherapy identify novel prognostic biomarkers in acute myeloid leukemia
    Meeting Abstract

    Raciti, P.; Hu, W. H.; Stranahan, A.; Woolthuis, C.; Devlin, S.; Park, C.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • CD99 identifies disease stem cells in acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS)
    Meeting Abstract

    Chung, S. S.; Devlin, S.; Park, C. Y.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • CD99 is a diagnostic and therapeutic target on disease stem cells in MDS and AML
    Meeting Abstract

    Chung, S. S.; Pang, W. W.; Devlin, S.; Klimek, V. M.; Melnick, A.; Park, C. Y.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • CD99 is a diagnostic and therapeutic target on disease stem cells in MDS and AML
    Meeting Abstract

    Chung, S. S.; Pang, W. W.; Devlin, S.; Klimek, V. M.; Melnick, A.; Park, C. Y.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • CD99 is a therapeutic target on disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes
    Meeting Abstract

    Chung, S. S.; Tavakkoli, M.; Devlin, S. M.; Park, C. Y.
    Blood (2013)

    Fulltext@MSK | Save